Navidea Biopharmaceuticals, Inc.
NAVBDelisted Jan 16, 2024- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000810509
Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Navidea Biopharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 2 | 1 | −1 |
| Shares | 360 | 5 | −355 (−98.6%) |
| Value | $0 | $0 | $0 |
New holders (1)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Runnymede Capital Advisors, Inc. | 5 | $0 | 0.00% |
Sold out (2)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Parallel Advisors, LLC | 350 | $0 |
| WR Wealth Planners, LLC | 10 | $0 |